DK0492667T3 - 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf - Google Patents
1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse derafInfo
- Publication number
- DK0492667T3 DK0492667T3 DK91122330.3T DK91122330T DK0492667T3 DK 0492667 T3 DK0492667 T3 DK 0492667T3 DK 91122330 T DK91122330 T DK 91122330T DK 0492667 T3 DK0492667 T3 DK 0492667T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzothiazine
- processes
- preparation
- acetic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP41531690 | 1990-12-27 | ||
JP21934691 | 1991-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0492667T3 true DK0492667T3 (da) | 1996-07-08 |
Family
ID=26523070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91122330.3T DK0492667T3 (da) | 1990-12-27 | 1991-12-27 | 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf |
Country Status (10)
Country | Link |
---|---|
US (1) | US5252571A (de) |
EP (1) | EP0492667B1 (de) |
JP (1) | JP2729430B2 (de) |
KR (1) | KR0156581B1 (de) |
AU (1) | AU634109B2 (de) |
CA (1) | CA2058398C (de) |
DE (1) | DE69118850T2 (de) |
DK (1) | DK0492667T3 (de) |
ES (1) | ES2085950T3 (de) |
IE (1) | IE914455A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2122370A1 (en) * | 1992-08-31 | 1994-03-17 | Yoichi Kawashima | 3-oxo-1,4-benzothiazine derivatives |
JPH06279453A (ja) * | 1993-03-29 | 1994-10-04 | Green Cross Corp:The | ピリドチアジン酢酸誘導体,その製法及びその用途 |
US5556841A (en) * | 1994-02-04 | 1996-09-17 | Santen Pharmaceutical Co., Ltd. | Thiazine or thiomorpholine derivatives |
US5700819A (en) * | 1994-11-29 | 1997-12-23 | Grelan Pharmaceutical Co., Ltd. | 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications |
JP2003119142A (ja) * | 1997-03-31 | 2003-04-23 | Mitsubishi Pharma Corp | 糖化蛋白変性物質生成阻害剤 |
AU5246400A (en) * | 1999-06-14 | 2001-01-02 | Mitsubishi Pharma Corporation | Process for the preparation of (-)-1,4-benzothiazine-2-acetic acid derivatives |
US8158667B2 (en) | 2006-08-21 | 2012-04-17 | Kador Peter F | Topical treatment of cataracts in dogs |
WO2012149567A1 (en) * | 2011-04-29 | 2012-11-01 | Mount Sinai School Of Medicine | Kinase inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1453465A (fr) * | 1965-08-11 | 1966-06-03 | Kuhlmann Ets | Nouveaux antiozones |
US3503965A (en) * | 1967-12-01 | 1970-03-31 | American Home Prod | Derivatives of 1,4-benzothiazine |
US3910904A (en) * | 1974-08-12 | 1975-10-07 | Monsanto Co | 2-Substituted methylene-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-4-acetic acid and esters thereof |
IE58312B1 (en) * | 1984-05-18 | 1993-09-08 | Union Pharma Scient Appl | Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors |
AU602641B2 (en) * | 1986-04-17 | 1990-10-18 | Senju Pharmaceutical Co., Ltd. | Thiolactam-N-acetic acid derivatives, their production and use |
-
1991
- 1991-12-19 IE IE445591A patent/IE914455A1/en not_active IP Right Cessation
- 1991-12-20 JP JP3354323A patent/JP2729430B2/ja not_active Expired - Fee Related
- 1991-12-23 CA CA002058398A patent/CA2058398C/en not_active Expired - Fee Related
- 1991-12-24 US US07/813,182 patent/US5252571A/en not_active Expired - Lifetime
- 1991-12-24 AU AU90045/91A patent/AU634109B2/en not_active Ceased
- 1991-12-27 KR KR1019910024962A patent/KR0156581B1/ko not_active IP Right Cessation
- 1991-12-27 EP EP91122330A patent/EP0492667B1/de not_active Expired - Lifetime
- 1991-12-27 DE DE69118850T patent/DE69118850T2/de not_active Expired - Fee Related
- 1991-12-27 DK DK91122330.3T patent/DK0492667T3/da active
- 1991-12-27 ES ES91122330T patent/ES2085950T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2729430B2 (ja) | 1998-03-18 |
EP0492667B1 (de) | 1996-04-17 |
KR0156581B1 (en) | 1998-11-16 |
DE69118850D1 (de) | 1996-05-23 |
KR920012056A (ko) | 1992-07-25 |
CA2058398C (en) | 2000-02-15 |
EP0492667A1 (de) | 1992-07-01 |
DE69118850T2 (de) | 1997-01-09 |
AU9004591A (en) | 1992-07-09 |
JPH0592961A (ja) | 1993-04-16 |
US5252571A (en) | 1993-10-12 |
CA2058398A1 (en) | 1992-06-28 |
ES2085950T3 (es) | 1996-06-16 |
AU634109B2 (en) | 1993-02-11 |
IE914455A1 (en) | 1992-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS3720A7 (is) | Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun | |
DK381485D0 (da) | 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf | |
DK577084D0 (da) | 2,2'iminobisethanol-derivater og fremgangsmaade til fremstilling deraf | |
NO902658D0 (no) | N-fenylpyrazolderivater, preparater og anvendelse derav. | |
NO902279D0 (no) | Benzocykloalkanderivater og fremstilling derav. | |
DK0562583T3 (da) | Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
DK0635004T3 (da) | 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf | |
NO900309L (no) | Benzocykloalkenyldihydroksyalkansyrederivater, og fremgangsmaate til fremstilling derav. | |
DK0435333T3 (da) | Cephalosporinderivater, fremgangsmåde til fremstilling deraf og antimikrobielt præparat indeholdende derivaterne | |
NO913686D0 (no) | Fremgangsmaate for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmaaten. | |
NO893826L (no) | Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater. | |
NO883082L (no) | Substituerte alkenkarboksylsyreamider og derivater. | |
NO882562D0 (no) | Nye 2-guanidino-tiazol-forbindelser fremgangsmaate for fremstilling derav og anvendelse derav. | |
NO972449D0 (no) | Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on 1,1 dioksidderivater og preparater og fremgangsmåte for anvendelse derav | |
DK165952C (da) | 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf | |
DK0492667T3 (da) | 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf | |
NO900643L (no) | Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater. | |
DK635988A (da) | 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater | |
DK10190D0 (da) | 1,1-dioxo-cephem-4-carbothiolsyrederivater | |
DE69122555D1 (de) | 2,4-Dihydroxyadipinsäurederivate | |
DK587689A (da) | 2-azabicyclo(2,2,1)hept-5-en-2-eddikesyre og derivater deraf, deres fremstilling og anvendelse | |
NO900252D0 (no) | Cefasporinderivater og fremgangsmaate for fremstilling derav. | |
DE69018816D1 (de) | Aminosäurederivate. | |
NO923455L (no) | Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler | |
DE59002430D1 (de) | Cyclopropanoylaminosäureamid-Derivate. |